Press Releases

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Oct 30, 2018

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

Oct 23, 2018

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

Oct 1, 2018

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

Sep 24, 2018

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Sep 12, 2018

NeoGenomics Announces Pricing on Public Offering of Common Stock

Aug 9, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

Aug 6, 2018

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Jul 24, 2018

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

Jul 2, 2018

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Jun 25, 2018

1
2
3
4
5
6
7
8
9
10